SCHEMBL13544631

SCHEMBL13544631

O=C(O)c1cnc2cn[nH]c2c1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM6B O15054 3/20 0.33
▸ KDM4A O75164 3/20 0.33
▸ KDM4D Q6B0I6 3/20 0.33
▸ HIF1AN Q9NWT6 3/20 0.33
▸ KDM2A Q9Y2K7 3/20 0.33
▸ PTK2 Q05397 2/20 0.33
▸ PLK4 O00444 1/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ DAPK3 O43293 1/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ CSF1R P07333 1/20 0.33
▸ RET P07949 1/20 0.33
▸ FGFR1 P11362 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ LTK P29376 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ MAP2K2 P36507 1/20 0.33
▸ FLT3 P36888 1/20 0.33
▸ CSNK1A1 P48729 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9073480 0.77 DAPK3 (0.40) PTK2PLK4CHEK1AURKADAPK3
SCHEMBL23629251 0.75 KDM5A (0.50) KDM4AKDM5BKDM5AKDM4C
SCHEMBL10567882 0.72 PTK2 (0.34) PTK2PLK4CHEK1AURKADAPK3
SCHEMBL2112360 0.71 CCNE2 (0.46) KDM6BKDM4AKDM4DHIF1ANKDM2A
SCHEMBL13544643 0.71 KDM4E (0.38) KDM6BKDM4AKDM4DHIF1ANKDM2A
SCHEMBL10563794 0.70 HCAR3 (0.41) KDM4EALDH1A1
SCHEMBL10565713 0.70 KDM6B (0.44) KDM6BKDM4AKDM4DHIF1ANKDM2A
SCHEMBL10568643 0.70 GRIN2D (0.38) KDM4EALDH1A1HPGDASPHKDM8
SCHEMBL29696512 0.69 PTK2 (0.33) PTK2PLK4CHEK1AURKADAPK3
SCHEMBL5134164 0.66 IL1B (0.45) KDM6BKDM4AKDM4DGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 — — US disclosed
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 — — US disclosed
Send feedback